Selective coronary revascularization for patients with carotid artery disease after carotid surgery
Official title: Selective Coronary Revascularization in Carotid Artery Disease Patients After Carotid Revascularization (SCORECAD Trial)
Run by Pauls Stradins Clinical University Hospital · NCT06546761 · Data updated 2026-11-12
This study is testing if adding a specific heart procedure to the best medical treatment can help prevent heart problems in patients over 50 who have had surgery for carotid artery disease.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 50 Years and up |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | Pauls Stradins Clinical University Hospital Academic / other |
| Locations | 1 site (Riga) |
| Status | Recruiting |
| Started | June 25, 2024 |
| Main results expected | June 25, 2027 |
| Study ends | June 25, 2029 |
| Registry record updated | August 9, 2024 |
| Trial ID | NCT06546761 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients aged 50 and older with symptomatic or asymptomatic carotid artery stenosis who have undergone carotid revascularization within the past 14 days.
✕Probably not a fit
Patients with known coronary artery disease or a history of myocardial infarction will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to evaluate whether a combination of best medical therapy and selective coronary revascularization, guided by FFRct assessment, can reduce adverse cardiac events in patients with carotid artery stenosis who have recently undergone carotid revascularization. Patients aged 50 and older, both symptomatic and asymptomatic, will be randomly assigned to receive either best medical therapy alone or best medical therapy plus coronary CT angiography and FFRct analysis. The study will follow participants for up to five years to assess the impact on cardiac outcomes. An independent committee will evaluate the clinical events to ensure unbiased results.
Why it matters
Potential benefit: If successful, this approach could significantly reduce the risk of cardiac events and improve survival rates in patients with carotid artery disease.
How similar studies have gone: While similar approaches have been explored, this specific combination of interventions is novel and has not been extensively tested in this patient population.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Inform consent obtained before any study-related activities; 2. Age above or equal to 50 years with symptomatic or asymptomatic critical carotid stenosis (symptomatic patients with at least Rankin III) which has been successfully revascularized by carotid endarterectomy or stenting within the past 14 days; 3. Willing and able to undergo coronary CTA scan within 14 days of randomization and agrees to submission of CTA data set for HeartFlow FFRct analysis with results made available to treating physician. Exclusion Criteria: 1. Known CAD, history of MI, prior coronary revascularization (PCI or CABG); 2. Patient underwent coronary angiography or coronary CTA before the randomization; 3. Known history of 2nd or 3rd degree heart block; sick sinus syndrome; long QT syndrome; 4. History of severe asthma, severe or bronchodilator-dependent Chronic obstructive pulmonary disease (COPD); 5. Severe congestive heart failure (NYHA III or IV); 6. Severe arrhythmia, prior pacemaker or internal defibrillator lead implantation; 7. Impaired chronic renal function (EPI-GFR\<30ml/min); 8. Subjects with known anaphylactic allergy to iodinated contrast; 9. Pregnancy or unknown pregnancy status in subject of childbearing potential; 10. Evidence of ongoing or active clinical instability, including acute chest pain (sudden onset), cardiogenic shock, unstable blood pressure with systolic blood pressure \<90 mmHg, or acute pulmonary edema; 11. Any active, serious, life-threatening disease with a life expectancy of less than 2 years; 12. Any active infection; 13. Inability to comply with study procedures; 14. Contraindication for guideline-guided long-term antiplatelet/anticoagulation regime after PCI/CABG; 15. Large neurologic deficit (Rankin scale \>III); 16. Participation in any interventional clinical study within 30 days prior to screening.
Where it's running
-
Pauls Stradins Clinical University Hospital
Riga, Latvia Recruiting
Study contacts
- Study coordinator: Dainis Krievins, MD, PhD
- Email: dainis.krievins@gmail.com
- Phone: +371 29450000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Simultaneous carotid artery stenting and cardiac surgery for high-risk patients
This study tests if doing carotid artery stenting at the same time as heart surgery can help high-risk patients with both conditions recover better and have fewer complications.
-
μFR-guided Drug-Coated Balloon Angioplasty vs Angiography-guided Angioplasty in Coronary Artery Disease
This trial tests whether using computational μFR guidance during drug-coated balloon angioplasty is better than standard angiography guidance for people with de novo coronary artery lesions.
-
Gastric Ultrasound Before CABG to See if Heart Function Changes Stomach Contents
This study checks whether people with weaker heart function before elective CABG have different stomach contents seen on ultrasound.
-
Can preoperative photon-counting CT help predict heart recovery after bypass surgery?
This observational study tests whether a preoperative photon-counting CT can help predict heart function 3 months after coronary bypass surgery in adults with coronary artery disease.
-
Real-World Drug-Coated Balloon Angioplasty in Coronary Artery Disease
This registry tests how drug-coated balloons perform in everyday clinical practice for adults with coronary artery disease undergoing PCI.
-
Predicting vasopressor needs after anesthesia in elective on-pump CABG using dynamic arterial elastance
This study tests whether EaDyn measured after induction can help predict which patients will need vasopressors during elective on-pump CABG.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.